Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

First Wave BioPharma Inc (FWBI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow First Wave BioPharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.1200 +0.1000    +3.31%
23/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
3.1500
+0.0300
+0.9615%
8:58:21 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 150,985
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 2.9000 - 3.3999
First Wave BioPharma 3.1200 +0.1000 +3.31%

FWBI Balance Sheet

 
Featured here, the Balance Sheet for First Wave BioPharma Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 4.96 3.98 2.35 3.53
Cash and Short Term Investments 3.71 3.29 1.24 2.06
Cash - - - -
Cash & Equivalents 3.71 3.29 1.24 2.06
Short Term Investments - - - -
Total Receivables, Net - - - 0.02
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses 1.24 0.684 1.12 1.45
Other Current Assets, Total - - - -
Total Assets 6.88 5.93 4.33 5.53
Property/Plant/Equipment, Total - Net 0.21 0.234 0.257 0.28
Property/Plant/Equipment, Total - Gross 0.283 0.3 0.316 0.332
Accumulated Depreciation, Total -0.073 -0.066 -0.059 -0.051
Goodwill, Net 1.68 1.68 1.68 1.68
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - - 0.02
Other Long Term Assets, Total 0.033 0.033 0.033 0.04
Other Assets, Total - - - -0.02
Total Current Liabilities 3.13 2.48 3.26 2.62
Accounts Payable 0.554 0.579 1.59 0.47
Payable/Accrued - - - -
Accrued Expenses 0.825 0.835 0.48 0.846
Notes Payable/Short Term Debt 0.613 - 0.153 0.38
Current Port. of LT Debt/Capital Leases 0.067 0.065 0.064 0.068
Other Current liabilities, Total 1.07 1 0.973 0.861
Total Liabilities 3.28 2.65 3.45 2.82
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total -0.466 0.166 0.031 -0.184
Total Equity 3.6 3.28 0.882 2.71
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 0.001 - -
Additional Paid-In Capital 187.93 183.51 177.68 175.32
Retained Earnings (Accumulated Deficit) -184.33 -180.23 -176.79 -172.6
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 6.88 5.93 4.33 5.53
Total Common Shares Outstanding 1.56 0.673 0.21 0.077
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FWBI Comments

Write your thoughts about First Wave BioPharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mario Dominici
Mario Dominici Jun 13, 2023 10:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
XCEL BRANDS! XCEL BRANDS AND G-III APPAREL GROUP, LTD. ANNOUNCE HALSTON MASTER LICENSING PARTNERSHIP UNDER NEW 25-YEAR AGREEMENT.
Binyamin Malka
Binyamin Malka Nov 01, 2021 10:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It’s show time! 🔥
Long Short
Long Short Sep 30, 2021 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Korea Bio company, Hyundai IBT, starts clinical trial based on niclosimide and its own drug delivery system technology. It may have amazing efficacy. Where is aarket for AZRX(FWBI)?
Saravanan Michael
Saravanan Michael Sep 29, 2021 9:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
due to reverse split buy price is 5.8. almost 40% loss. :(
Martin Badinelli
Martin Badinelli Sep 29, 2021 9:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You mean 2.80 or 70% loss!
Binyamin Malka
Binyamin Malka Sep 13, 2021 3:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats going on…?
Fred Lop
Fred Lop Sep 13, 2021 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
After september 23 new name FWBI
Fred Lop
Fred Lop Sep 13, 2021 9:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.marketwatch.com/amp/story/azurrx-biopharma-to-buy-first-wave-bio-for-229m-in-cash-stock-271631528016
Jean Mercredi
Jean Mercredi Sep 13, 2021 9:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What the hell?
Batuhan Babür
Batuhan Babür Sep 13, 2021 9:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Reverse split
Миша Тюрин
Миша Тюрин Sep 13, 2021 7:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Reverse split? Or extraordinary pump? Since 2021 i dont believe in miracles haha
CJ Huffman
CJ Huffman Sep 13, 2021 7:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1:10 Reverse split
Mohamed Shaibi
Mohamed Shaibi Aug 24, 2021 7:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock like to stay qroud. 0.50 - 0.55
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email